Pulmonary disease prevalence increases with age and contributes to morbidity and mortality
in older patients. Dyspnea in older patients is often ascribed to multiple etiologies such as …

Background The widespread use of inhaled corticosteroids (ICSs) for COPD treatment has
been questioned. Recent studies of weaning some patients with COPD off ICSs found little …

To investigate the aetiology of cataract, it is necessary to measure both the type and severity
of lens opacities, as well as the dose and duration of exposure to the putative risk factor …

A major burden of severe asthma is the future risk of adverse health outcomes. Patients with
severe asthma are prone to serious exacerbation and deterioration of lung function and may …

OBJECTIVE: Until recently, inhaled corticosteroids were not considered to cause elevated
intraocular pressure (IOP), although topical and oral corticosteroids have been shown to do …

Background: The relative risk of diabetes among patients undergoing risperidone treatment
was compared with that of patients receiving olanzapine. Method: A cohort was formed of …

Inhaled glucocorticosteroids (ICS) are commonly prescribed for chronic obstructive
pulmonary disease. No adverse effect on bone mineral density (BMD) has been proven. In a …

Orally inhaled corticosteroid use has been convincingly linked to an increase in the risk of
cataracts, although the risk at lower doses in common use remains uncertain. The potential …

Background and objective: The risk of cataracts associated with the long‐term use of inhaled
corticosteroids (ICS) is poorly recognized, yet may be of major public health importance. The …

Background/aims: Exposure to systemic corticosteroid use is known to be associated with a
risk of cataract. Whether low doses of inhaled corticosteroids are associated with an …